StreetInsider.com News Articles

Form 8-K IMMUCELL CORP /DE/ For: Jul 09

Thu, 09 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260709/26753287.html

Form 8-K IMMUCELL CORP /DE/ For: Jul 09

Thu, 09 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260709/26753287.html

ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half

Thu, 09 Jul 2026 16:06:06 -0400

ImmuCell Corporation (Nasdaq: ICCC) reported preliminary, unaudited total product sales of $7.2 million for the three months ended June 30, 2026, an 11.5% increase from $6.4 million in the same period of 2025, according to a company press release.

Domestic sales drove the quarterly result, rising 27.7% to $6.2 million from $4.9 million a year earlier. International sales fell 38.9% to $1.0 million from $1.6 million in the prior-year quarter.

By product, Tri-Shield First Defense sales reached $4.9 million in Q2 2026, up 8.3% from $4.5 million, while Dual-Force and other sales rose 19.1% to $2.3 million from $1.9 million.

For the six

ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half

Thu, 09 Jul 2026 16:06:06 -0400

Domestic sales drove the quarterly result, rising 27.7% to $6.2 million from $4.9 million a year earlier. International sales fell 38.9% to $1.0 million from $1.6 million in the prior-year quarter.

By product, Tri-Shield First Defense sales reached $4.9 million in Q2 2026, up 8.3% from $4.5 million, while Dual-Force and other sales rose 19.1% to $2.3 million from $1.9 million.

For the six

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

Thu, 09 Jul 2026 16:05:00 -0400

PORTLAND, Maine, July 09, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced preliminary, unaudited sales results for the second quarter of 2026.

“Total sales for the three months ended June 30, 2026 were $7.2 million, an 11.5% increase compared to the three months ended June 30, 2025, driven by a 27.7% increase in domestic sales compared to 2025,” said Timothy Fiori, Chief Financial Officer of ImmuCell. “Our growth in the second quarter is particularly significant given

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

Thu, 09 Jul 2026 16:05:00 -0400

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

Thu, 09 Jul 2026 16:05:00 -0400

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

Thu, 09 Jul 2026 16:05:00 -0400

Form 4 IMMUCELL CORP /DE/ For: Jun 18 Filed by: te Boekhorst Paul Francis Olivier

Mon, 22 Jun 2026 08:34:00 -0400

si-local-file:///var/storage/secattach/20260622/26670463.html

Form 4 IMMUCELL CORP /DE/ For: Jun 18 Filed by: te Boekhorst Paul Francis Olivier

Mon, 22 Jun 2026 08:34:00 -0400

si-local-file:///var/storage/secattach/20260622/26670463.html

Form 8-K IMMUCELL CORP /DE/ For: Jun 11

Wed, 17 Jun 2026 14:19:00 -0400

si-local-file:///var/storage/secattach/20260617/26659308.html

Form 8-K IMMUCELL CORP /DE/ For: Jun 11

Wed, 17 Jun 2026 14:19:00 -0400

si-local-file:///var/storage/secattach/20260617/26659308.html

Form 8-K IMMUCELL CORP /DE/ For: Jun 04

Wed, 10 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260610/26629843.html

Form 8-K IMMUCELL CORP /DE/ For: Jun 04

Wed, 10 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260610/26629843.html

Immucell Corp (ICCC) Reports Q1 EPS of $0.21

Thu, 14 May 2026 16:21:06 -0400

Immucell Corp (NASDAQ: ICCC) reported Q1 EPS of $0.21. Revenue for the quarter came in at $10.36 million, versus $0 reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

Form 8-K IMMUCELL CORP /DE/ For: May 14

Thu, 14 May 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260514/26494875.html

Form 8-K IMMUCELL CORP /DE/ For: May 14

Thu, 14 May 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260514/26494875.html

Form 10-Q IMMUCELL CORP /DE/ For: Mar 31

Thu, 14 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260514/26494804.html

Form 10-Q IMMUCELL CORP /DE/ For: Mar 31

Thu, 14 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260514/26494804.html

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

Thu, 14 May 2026 16:05:00 -0400

PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, today announced its unaudited financial results for the quarter ended March 31, 2026.

Management’s Discussion:

“Today we are reporting net income of $1.9 million for the first quarter of 2026, which is an increase of $0.5 million compared to the first quarter of 2025,” commented Timothy C. Fiori, Chief Financial Officer of ImmuCell. “These results were driven by 28.4% growth in product sales

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

Thu, 14 May 2026 16:05:00 -0400

Management’s Discussion:

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

Thu, 14 May 2026 16:05:00 -0400

Management’s Discussion:

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

Thu, 14 May 2026 16:05:00 -0400

Management’s Discussion:

Form 10-K/A IMMUCELL CORP /DE/ For: Dec 31

Wed, 13 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260513/26485975.html

Form 10-K/A IMMUCELL CORP /DE/ For: Dec 31

Wed, 13 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260513/26485975.html